Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells

Lars Tögel(Friedrich-Alexander-Universität Erlangen-Nürnberg), John M. Mariadason(Olivia Newton-John Cancer Wellness & Research Centre)

Molecular Cancer Therapeutics

March 16, 2016

10.1158/1535-7163.mct-15-0724

Cited by 89

Related Papers

Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer

|Oral Oncology|2012|91

Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets

|iScience|2019|22

DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis

|Scientific Reports|2018|19